In vitro and ex vivo autoradiographic studies of nicotinic acetylcholine receptors using [18F]fluoronorchloroepibatidine in rodent and human brain

被引:25
作者
Gatley, SJ
Ding, YS
Brady, D
Gifford, AN
Dewey, SL
Carroll, FI
Fowler, JS
Volkow, ND
机构
[1] Brookhaven Natl Lab, Dept Med, Upton, NY 11973 USA
[2] Brookhaven Natl Lab, Dept Chem, Upton, NY 11973 USA
[3] NIA, Neurosci Lab, Bethesda, MD 20892 USA
[4] Res Triangle Inst, Res Triangle Pk, NC 27709 USA
[5] SUNY Stony Brook, Dept Psychiat, Stony Brook, NY 11786 USA
关键词
epibatidine; nicotinic receptor; thalamus; fluorine-18; phosphor imaging;
D O I
10.1016/S0969-8051(98)00007-9
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
A fluorine-18-labeled analog of the potent nicotinic agonist epibatidine is a candidate radioligand for positron emission tomographic (PET) studies of nicotinic acetylcholine receptors (nAcChR). Following intravenous administration of [F-18]exo-2-(2'-fluoro-5'-pyridinyl)-7-azabicylo[2.2.1]heptane (NFEP), high uptake in thalamus was visualized in sections of mouse and rat brain by autoradiography using a phosphor imaging, device. Binding of [[F-18]NFEP to rat thalamic homogenate was consistent with a single class of binding site with a Kd value of 71 FM. In vitro autoradiography of thaw-mounted sections of human thalamus revealed a heterogeneous pattern of binding; Bmax values for ventrolateral nucleus, insular cortex and dorsomedial nucleus, and internal capsule were 20, 8, and 3 pmol/cc of tissue, respectively. However, similar Kd values close to 50 pM were calculated for all regions. These studies support the suitability of [F-18]NFEP as a radioligand for PET studies of nAcChR in the living human brain. NUCL MED BIOL 25;5: 449-454 1998. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:449 / 454
页数:6
相关论文
共 50 条
  • [31] MARKS MJ, 1986, MOL PHARMACOL, V30, P427
  • [32] MARTINOBARROWS AM, 1987, MOL PHARMACOL, V31, P169
  • [33] Fluoro-norchloroepibatidine: Preclinical assessment of acute toxicity
    Molina, PE
    Ding, YS
    Carroll, FI
    Liang, F
    Volkow, ND
    Pappas, N
    Kuhar, M
    Abumrad, N
    Gatley, SJ
    Fowler, JS
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 1997, 24 (08): : 743 - 747
  • [34] UPTAKE AND REGIONAL DISTRIBUTION OF (+)-(R)-N-[METHYL-C-11]-NICOTINE AND (-)-(S)-N-[METHYL-C-11]-NICOTINE IN THE BRAINS OF RHESUS-MONKEY - AN ATTEMPT TO STUDY NICOTINIC RECEPTORS INVIVO
    NORDBERG, A
    HARTVIG, P
    LUNDQVIST, H
    ANTONI, G
    ULIN, J
    LANGSTROM, B
    [J]. JOURNAL OF NEURAL TRANSMISSION-PARKINSONS DISEASE AND DEMENTIA SECTION, 1989, 1 (03) : 195 - 205
  • [35] PABREZA LA, 1991, MOL PHARMACOL, V39, P9
  • [36] PERRY DC, 1995, J PHARMACOL EXP THER, V275, P1030
  • [37] QIAN CG, 1993, EUR J PHARMACOL, V250, pR13
  • [38] HIGH-AFFINITY BINDING OF [H-3] (-)-NICOTINE TO RAT-BRAIN MEMBRANES AND ITS INHIBITION BY ANALOGS OF NICOTINE
    REAVILL, C
    JENNER, P
    KUMAR, R
    STOLERMAN, IP
    [J]. NEUROPHARMACOLOGY, 1988, 27 (03) : 235 - 241
  • [39] DISTRIBUTION OF NEURONAL NICOTINIC RECEPTOR SUBUNITS IN HUMAN BRAIN
    RUBBOLI, F
    COURT, JA
    SALA, C
    MORRIS, C
    PERRY, E
    CLEMENTI, F
    [J]. NEUROCHEMISTRY INTERNATIONAL, 1994, 25 (01) : 69 - 71
  • [40] DISTRIBUTION OF NICOTINIC RECEPTORS IN THE HUMAN HIPPOCAMPUS AND THALAMUS
    RUBBOLI, F
    COURT, JA
    SALA, C
    MORRIS, C
    CHINI, B
    PERRY, E
    CLEMENTI, F
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 1994, 6 (10) : 1596 - 1604